| Medical Condition | Type II Diabetes |
| Facility/Clinic | Accellacare – 1917 Tradd Ct |
| Age | 18+ |
| Gender | Male & Female |
| Description | A 48-week, phase 3 study to investigate the efficacy and safety of Retatrutide compared with placebo in adult participants with type II diabetes and inadequate glycemic control with diet and exercise alone. |
| Enrollment | Open |
| Patient Commitment Duration | 48 weeks |
| Number of visits in study | 12-16 |
| Patient Compensation | Visit 1-11 – $2,016 (price varies per visit) / Visit 801- $168 / Unscheduled Visits – $84 / Early Discontinuation – $224 |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.